Alex Menchaca’s Article “What the Minerva Supreme Court Decision Could Mean for the Medical Device World and Beyond” Featured in MD&DI


The long-standing patent law doctrine at issue is called “assignee estoppel.” Assignee estoppel prevents an inventor or selling company from challenging the validity of a patent after the patent has been acquired by a purchasing company.

Read the article here.